+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Base Editing Market 2024-2028

  • PDF Icon

    Report

  • 148 Pages
  • December 2023
  • Region: Global
  • TechNavio
  • ID: 5923893
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The base editing market is forecasted to grow by USD 307.66 mn during 2023-2028, accelerating at a CAGR of 15.1% during the forecast period. The report on the base editing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in applications of genome editing in therapeutics, increasing research activities in pharmaceutical and biotechnology sectors, and increasing demand for genetically edited crops.

The base editing market is segmented as below:

By Application

  • Drug discovery and development
  • Agriculture
  • Veterinary

By Type

  • DNA base editing
  • RNA base editing

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the technological advancement in genome editing tools as one of the prime reasons driving the base editing market growth during the next few years. Also, growing developments in precision medicine and gene therapy and advances in genome editing tools to improve the development of vaccines will lead to sizable demand in the market.

The report on the base editing market covers the following areas:

  • Base editing market sizing
  • Base editing market forecast
  • Base editing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading base editing market vendors that include Beam Therapeutics Inc., Bio Palette Co. Ltd., Cellectis SA, Creative Biogene, Danaher Corp., EdiGene Inc., ElevateBio, Genkore Co. Ltd., GenScript Biotech Corp., Horizon Discovery Ltd., Intellia Therapeutics Inc., KromaTiD Inc., Maravai LifeSciences Holdings Inc., Merck KGaA, Pairwise Plants Services, PerkinElmer Inc, ProQR Therapeutics NV, QI Biodesign Biotechnology Co. Ltd., Shape Therapeutics Inc., and Synthego Corp.. Also, the base editing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global base editing market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global base editing market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Drug discovery and development - Market size and forecast 2023-2028
Exhibit 34: Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%)
6.4 Agriculture - Market size and forecast 2023-2028
Exhibit 38: Chart on Agriculture - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Agriculture - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Agriculture - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Agriculture - Year-over-year growth 2023-2028 (%)
6.5 Veterinary - Market size and forecast 2023-2028
Exhibit 42: Chart on Veterinary - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Veterinary - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Veterinary - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Veterinary - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ million)
Exhibit 47: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2023-2028 (%)
Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 DNA base editing - Market size and forecast 2023-2028
Exhibit 52: Chart on DNA base editing - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on DNA base editing - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on DNA base editing - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on DNA base editing - Year-over-year growth 2023-2028 (%)
7.4 RNA base editing - Market size and forecast 2023-2028
Exhibit 56: Chart on RNA base editing - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on RNA base editing - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on RNA base editing - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on RNA base editing - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 60: Market opportunity by Type ($ million)
Exhibit 61: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Beam Therapeutics Inc.
Exhibit 111: Beam Therapeutics Inc. - Overview
Exhibit 112: Beam Therapeutics Inc. - Product / Service
Exhibit 113: Beam Therapeutics Inc. - Key offerings
12.4 Bio Palette Co. Ltd.
Exhibit 114: Bio Palette Co. Ltd. - Overview
Exhibit 115: Bio Palette Co. Ltd. - Product / Service
Exhibit 116: Bio Palette Co. Ltd. - Key offerings
12.5 Cellectis SA
Exhibit 117: Cellectis SA - Overview
Exhibit 118: Cellectis SA - Product / Service
Exhibit 119: Cellectis SA - Key offerings
12.6 Creative Biogene
Exhibit 120: Creative Biogene - Overview
Exhibit 121: Creative Biogene - Product / Service
Exhibit 122: Creative Biogene - Key offerings
12.7 Danaher Corp.
Exhibit 123: Danaher Corp. - Overview
Exhibit 124: Danaher Corp. - Business segments
Exhibit 125: Danaher Corp. - Key news
Exhibit 126: Danaher Corp. - Key offerings
Exhibit 127: Danaher Corp. - Segment focus
12.8 EdiGene Inc.
Exhibit 128: EdiGene Inc. - Overview
Exhibit 129: EdiGene Inc. - Product / Service
Exhibit 130: EdiGene Inc. - Key offerings
12.9 ElevateBio
Exhibit 131: ElevateBio - Overview
Exhibit 132: ElevateBio - Product / Service
Exhibit 133: ElevateBio - Key offerings
12.10 GenScript Biotech Corp.
Exhibit 134: GenScript Biotech Corp. - Overview
Exhibit 135: GenScript Biotech Corp. - Business segments
Exhibit 136: GenScript Biotech Corp. - Key news
Exhibit 137: GenScript Biotech Corp. - Key offerings
Exhibit 138: GenScript Biotech Corp. - Segment focus
12.11 Intellia Therapeutics Inc.
Exhibit 139: Intellia Therapeutics Inc. - Overview
Exhibit 140: Intellia Therapeutics Inc. - Product / Service
Exhibit 141: Intellia Therapeutics Inc. - Key offerings
12.12 Maravai LifeSciences Holdings Inc.
Exhibit 142: Maravai LifeSciences Holdings Inc. - Overview
Exhibit 143: Maravai LifeSciences Holdings Inc. - Business segments
Exhibit 144: Maravai LifeSciences Holdings Inc. - Key offerings
Exhibit 145: Maravai LifeSciences Holdings Inc. - Segment focus
12.13 Merck KGaA
Exhibit 146: Merck KGaA - Overview
Exhibit 147: Merck KGaA - Business segments
Exhibit 148: Merck KGaA - Key news
Exhibit 149: Merck KGaA - Key offerings
Exhibit 150: Merck KGaA - Segment focus
12.14 PerkinElmer Inc
Exhibit 151: PerkinElmer Inc - Overview
Exhibit 152: PerkinElmer Inc - Business segments
Exhibit 153: PerkinElmer Inc - Key news
Exhibit 154: PerkinElmer Inc - Key offerings
Exhibit 155: PerkinElmer Inc - Segment focus
12.15 ProQR Therapeutics NV
Exhibit 156: ProQR Therapeutics NV - Overview
Exhibit 157: ProQR Therapeutics NV - Product / Service
Exhibit 158: ProQR Therapeutics NV - Key offerings
12.16 Shape Therapeutics Inc.
Exhibit 159: Shape Therapeutics Inc. - Overview
Exhibit 160: Shape Therapeutics Inc. - Product / Service
Exhibit 161: Shape Therapeutics Inc. - Key offerings
12.17 Synthego Corp.
Exhibit 162: Synthego Corp. - Overview
Exhibit 163: Synthego Corp. - Product / Service
Exhibit 164: Synthego Corp. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global base editing market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Application - Market share 2023-2028 (%)
Exhibits 31: Data Table on Application - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Agriculture - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Agriculture - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Agriculture - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Agriculture - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Veterinary - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Veterinary - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Veterinary - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Veterinary - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Application ($ million)
Exhibits 47: Data Table on Market opportunity by Application ($ million)
Exhibits 48: Chart on Type - Market share 2023-2028 (%)
Exhibits 49: Data Table on Type - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Type
Exhibits 51: Data Table on Comparison by Type
Exhibits 52: Chart on DNA base editing - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on DNA base editing - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on DNA base editing - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on DNA base editing - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on RNA base editing - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on RNA base editing - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on RNA base editing - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on RNA base editing - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by Type ($ million)
Exhibits 61: Data Table on Market opportunity by Type ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2023 and 2028
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Beam Therapeutics Inc. - Overview
Exhibits 112: Beam Therapeutics Inc. - Product / Service
Exhibits 113: Beam Therapeutics Inc. - Key offerings
Exhibits 114: Bio Palette Co. Ltd. - Overview
Exhibits 115: Bio Palette Co. Ltd. - Product / Service
Exhibits 116: Bio Palette Co. Ltd. - Key offerings
Exhibits 117: Cellectis SA - Overview
Exhibits 118: Cellectis SA - Product / Service
Exhibits 119: Cellectis SA - Key offerings
Exhibits 120: Creative Biogene - Overview
Exhibits 121: Creative Biogene - Product / Service
Exhibits 122: Creative Biogene - Key offerings
Exhibits 123: Danaher Corp. - Overview
Exhibits 124: Danaher Corp. - Business segments
Exhibits 125: Danaher Corp. - Key news
Exhibits 126: Danaher Corp. - Key offerings
Exhibits 127: Danaher Corp. - Segment focus
Exhibits 128: EdiGene Inc. - Overview
Exhibits 129: EdiGene Inc. - Product / Service
Exhibits 130: EdiGene Inc. - Key offerings
Exhibits 131: ElevateBio - Overview
Exhibits 132: ElevateBio - Product / Service
Exhibits 133: ElevateBio - Key offerings
Exhibits 134: GenScript Biotech Corp. - Overview
Exhibits 135: GenScript Biotech Corp. - Business segments
Exhibits 136: GenScript Biotech Corp. - Key news
Exhibits 137: GenScript Biotech Corp. - Key offerings
Exhibits 138: GenScript Biotech Corp. - Segment focus
Exhibits 139: Intellia Therapeutics Inc. - Overview
Exhibits 140: Intellia Therapeutics Inc. - Product / Service
Exhibits 141: Intellia Therapeutics Inc. - Key offerings
Exhibits 142: Maravai LifeSciences Holdings Inc. - Overview
Exhibits 143: Maravai LifeSciences Holdings Inc. - Business segments
Exhibits 144: Maravai LifeSciences Holdings Inc. - Key offerings
Exhibits 145: Maravai LifeSciences Holdings Inc. - Segment focus
Exhibits 146: Merck KGaA - Overview
Exhibits 147: Merck KGaA - Business segments
Exhibits 148: Merck KGaA - Key news
Exhibits 149: Merck KGaA - Key offerings
Exhibits 150: Merck KGaA - Segment focus
Exhibits 151: PerkinElmer Inc - Overview
Exhibits 152: PerkinElmer Inc - Business segments
Exhibits 153: PerkinElmer Inc - Key news
Exhibits 154: PerkinElmer Inc - Key offerings
Exhibits 155: PerkinElmer Inc - Segment focus
Exhibits 156: ProQR Therapeutics NV - Overview
Exhibits 157: ProQR Therapeutics NV - Product / Service
Exhibits 158: ProQR Therapeutics NV - Key offerings
Exhibits 159: Shape Therapeutics Inc. - Overview
Exhibits 160: Shape Therapeutics Inc. - Product / Service
Exhibits 161: Shape Therapeutics Inc. - Key offerings
Exhibits 162: Synthego Corp. - Overview
Exhibits 163: Synthego Corp. - Product / Service
Exhibits 164: Synthego Corp. - Key offerings
Exhibits 165: Inclusions checklist
Exhibits 166: Exclusions checklist
Exhibits 167: Currency conversion rates for US$
Exhibits 168: Research methodology
Exhibits 169: Validation techniques employed for market sizing
Exhibits 170: Information sources
Exhibits 171: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global base editing market: Beam Therapeutics Inc., Bio Palette Co. Ltd., Cellectis SA, Creative Biogene, Danaher Corp., EdiGene Inc., ElevateBio, Genkore Co. Ltd., GenScript Biotech Corp., Horizon Discovery Ltd., Intellia Therapeutics Inc., KromaTiD Inc., Maravai LifeSciences Holdings Inc., Merck KGaA, Pairwise Plants Services, PerkinElmer Inc, ProQR Therapeutics NV, QI Biodesign Biotechnology Co. Ltd., Shape Therapeutics Inc., and Synthego Corp..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advancement in genome editing tools.'

According to the report, one of the major drivers for this market is the increase in applications of genome editing in therapeutics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Beam Therapeutics Inc.
  • Bio Palette Co. Ltd.
  • Cellectis SA
  • Creative Biogene
  • Danaher Corp.
  • EdiGene Inc.
  • ElevateBio
  • Genkore Co. Ltd.
  • GenScript Biotech Corp.
  • Horizon Discovery Ltd.
  • Intellia Therapeutics Inc.
  • KromaTiD Inc.
  • Maravai LifeSciences Holdings Inc.
  • Merck KGaA
  • Pairwise Plants Services
  • PerkinElmer Inc
  • ProQR Therapeutics NV
  • QI Biodesign Biotechnology Co. Ltd.
  • Shape Therapeutics Inc.
  • Synthego Corp.